carboxyatractyloside has been researched along with ubiquinone in 1 studies
| Studies (carboxyatractyloside) | Trials (carboxyatractyloside) | Recent Studies (post-2010) (carboxyatractyloside) | Studies (ubiquinone) | Trials (ubiquinone) | Recent Studies (post-2010) (ubiquinone) |
|---|---|---|---|---|---|
| 261 | 0 | 22 | 9,497 | 597 | 3,655 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barajas, M; Griffiths, KK; Homma, S; Levy, RJ; Liu, R; Matsumoto, K; Wang, A | 1 |
1 other study(ies) available for carboxyatractyloside and ubiquinone
| Article | Year |
|---|---|
The newborn Fmr1 knockout mouse: a novel model of excess ubiquinone and closed mitochondrial permeability transition pore in the developing heart.
Topics: Animals; Atractyloside; Cyclosporine; Disease Models, Animal; Electron Transport; Fetal Heart; Fragile X Mental Retardation Protein; Fragile X Syndrome; Guanosine Diphosphate; Male; Mice; Mice, Knockout; Mitochondria, Heart; Mitochondrial Permeability Transition Pore; Myocytes, Cardiac; Oxygen Consumption; Proton-Motive Force; Single-Blind Method; Ubiquinone | 2021 |